Understanding how alarmins like TSLP and IL-25 act combinatorially to regulate innate type 2 immunity in support of local physiologic pathways, as co-opted by intestinal pathobionts to sustain their niche, may enable new strategies for increasing tissue resilience while avoiding the dysregulated state of allergic disease. This evidence concerns the gene IL25 and allergic disease.